Drug Type Small molecule drug |
Synonyms- |
Action inhibitors, agonists |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Clinical | United States | 01 Jul 2019 |
Not Applicable | 401 | Intravitreal Triamcinolone Acetonide-Moxifloxacin | wtbapxrakp(ltkvolzokg) = cganzhqhzw plkmnjmhqy (intsfiwhpn ) | - | 01 Jun 2021 | ||
Intracameral Dexamethasone-Moxifloxacin-Ketorolac | wtbapxrakp(ltkvolzokg) = vmqpcihtfh plkmnjmhqy (intsfiwhpn ) | ||||||
Not Applicable | 198 | Intraoperative Triamcinolone-Moxifloxacin Injection | tdduoayilo(idhuafhxky) = szvjqrfqzb qgeyrjxunr (hbatafnduq ) | Positive | 01 Jun 2020 | ||
Postoperative Polymyxin B/Trimethoprim and Prednisolone Acetate 1% Eye Drops | tdduoayilo(idhuafhxky) = xcglwmulpi qgeyrjxunr (hbatafnduq ) |